Correlation Between Recursion Pharmaceuticals and Maptelligent
Can any of the company-specific risk be diversified away by investing in both Recursion Pharmaceuticals and Maptelligent at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Recursion Pharmaceuticals and Maptelligent into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Recursion Pharmaceuticals and Maptelligent, you can compare the effects of market volatilities on Recursion Pharmaceuticals and Maptelligent and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Recursion Pharmaceuticals with a short position of Maptelligent. Check out your portfolio center. Please also check ongoing floating volatility patterns of Recursion Pharmaceuticals and Maptelligent.
Diversification Opportunities for Recursion Pharmaceuticals and Maptelligent
-0.37 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Recursion and Maptelligent is -0.37. Overlapping area represents the amount of risk that can be diversified away by holding Recursion Pharmaceuticals and Maptelligent in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Maptelligent and Recursion Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Recursion Pharmaceuticals are associated (or correlated) with Maptelligent. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Maptelligent has no effect on the direction of Recursion Pharmaceuticals i.e., Recursion Pharmaceuticals and Maptelligent go up and down completely randomly.
Pair Corralation between Recursion Pharmaceuticals and Maptelligent
Given the investment horizon of 90 days Recursion Pharmaceuticals is expected to generate 0.48 times more return on investment than Maptelligent. However, Recursion Pharmaceuticals is 2.07 times less risky than Maptelligent. It trades about 0.01 of its potential returns per unit of risk. Maptelligent is currently generating about -0.21 per unit of risk. If you would invest 732.00 in Recursion Pharmaceuticals on September 14, 2024 and sell it today you would lose (34.00) from holding Recursion Pharmaceuticals or give up 4.64% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 95.45% |
| Values | Daily Returns |
Recursion Pharmaceuticals vs. Maptelligent
Performance |
| Timeline |
| Recursion Pharmaceuticals |
| Maptelligent |
Recursion Pharmaceuticals and Maptelligent Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Recursion Pharmaceuticals and Maptelligent
The main advantage of trading using opposite Recursion Pharmaceuticals and Maptelligent positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Recursion Pharmaceuticals position performs unexpectedly, Maptelligent can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Maptelligent will offset losses from the drop in Maptelligent's long position.| Recursion Pharmaceuticals vs. Absci Corp | Recursion Pharmaceuticals vs. Affimed NV | Recursion Pharmaceuticals vs. Sana Biotechnology | Recursion Pharmaceuticals vs. Relay Therapeutics |
| Maptelligent vs. Mojo Data Solutions | Maptelligent vs. UBI Blockchain Internet | Maptelligent vs. TrackX Holdings | Maptelligent vs. Obocon Inc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Other Complementary Tools
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |